Psychiatric Times

JULY 1, 2025

SHOW MORE The FDA will update ADHD medication labels, warning of weight loss risks in children under 6, urging careful monitoring by health care professionals. Health care professionals should monitor the child’s growth and development and provide necessary interventions to mitigate weight loss.”

Genetics and mental health 98

Genetics and mental health Bipolar disorder Sleep and mental health Aging and mental health 98

Psychiatric Times

JUNE 23, 2025

1 The newly announced CNPV pathway was introduced by FDA Commissioner Marty Makary, MD, MPH, on June 17, 2025, and is intended to expedite reviews for medications that address US public health priorities. The CNPV program, introduced by FDA Commissioner Marty Makary, aims to reduce review times to 1-2 months for eligible applications.

Pharmaceuticals 95

Pharmaceuticals Bipolar disorder Genetics and mental health Manufacturing 95

Psychiatric Times

JULY 7, 2025

Learn more in this exclusive article. Together, they will aim to bring innovative mental health treatments to patients in need. Participants include 30 young adults diagnosed with BPD and 20 young adults with no mental health diagnosis, who are observed using EEG and behavioral assessments to gather objective data.

Pharmaceuticals 85

Pharmaceuticals Sleep and mental health Genetics and mental health Technology 85

Lightwork

APRIL 17, 2025

Navigating medication safety during pregnancy can feel overwhelming, especially for women managing mental health conditions. For women with mental health conditions, the decision to use ondansetron requires careful consideration.

Neurotransmitters and mental health 52

Neurotransmitters and mental health Genetics and mental health Nutrition and mood Sleep and mental health 52

Lightwork

MAY 1, 2025

Research shows women develop substance dependencies faster than men and experience more severe health consequences from prolonged substance use. Addressing Mental Health in Women’s Recovery Journey Mental health care plays a vital role in women’s addiction recovery.

Dialectical Behavior Therapy 52

Dialectical Behavior Therapy Resilience and coping Genetics and mental health Insurance 52

Psychiatric Times

JUNE 18, 2025

Studies in Australia and the United States followed individuals with subthreshold psychotic symptoms and functional decline, along with a genetic risk for schizophrenia, over time. Research indicates that only 20% to 40% of individuals who meet ultra–high risk (UHR) criteria convert to psychosis within 2 to 4 years.

Genetics and mental health 64

Genetics and mental health Sleep and mental health Bipolar disorder Early intervention 64

ADDitude

MAY 23, 2025

The MAHA Report , spearheaded by Health and Human Service (HHS) Secretary Robert F. It disregards the genetic underpinnings of ADHD to suggest it is caused by environmental factors and foods, twists data to stoke fear over rising diagnosis rates, and excludes a wealth of studies that link stimulant medication use to improved health outcomes.

Genetics and mental health 111

Genetics and mental health Sleep and mental health Aging and mental health Dialectical Behavior Therapy 111